Like with any illness, a proper diagnosis of prostate cancer is essential since it might influence the types of therapies doctors may choose to utilize to get the greatest results. Yet, as new technologies develop, experts are searching for ways to enhance the method now used to diagnose prostate cancer.Findings from a trial being conducted at the University Hospital Bonn in Germany, called the DEPROMP trial, suggests that the use of a specialized imaging technique, called PSMA-PET/CT, could help with the detection and diagnosis of prostate cancer by providing a clearer image of a person’s tumor. Study findings are published in Trials.Currently, standard of care for prostate cancer biopsy involves an MRI scan to give a clinician a sense of a patient’s tumor before performing the biopsy.